等待开盘 06-25 09:30:00 美东时间
+0.410
+0.90%
JFB Construction (JFB) said on Tuesday that XTEND had secured a multi-million-dollar contract for more than 100 Scorpio drone systems in Asia-Pacific. JFB Construction and XTEND entered into a definit...
06-09 20:52
Significant Asia-Pacific Contract to Date Expands XOS Deployment Footprint and Strengthens International Orders BacklogTAMPA, Fla., June 09, 2026 (GLOBE NEWSWIRE) -- JFB Construction Holdings (NASDAQ:JFB) announced today
06-09 20:35
JFB Construction says XTEND wins $3 million Asia-Pacific order for 100 Scorpio drone systems JFB Construction Holdings disclosed a $3 million Asia-Pacific defense contract for XTEND to deliver more than 100 XOS-enabled Scorpio drone systems. Deliveries scheduled to start in 2026, extending into 2027
06-09 20:32
JFB Construction shares are trading higher after the company announced that XTE...
05-29 02:13
AI robotics company validated by the U.S. DoW and trialed with British Forces establishes sovereign manufacturing hub to support NATO-aligned autonomous defense capabilitiesTampa, FL, May 20, 2026 (GLOBE NEWSWIRE) -- JFB
05-20 20:33
Unusual Machines hosts live drone ecosystem demos at XPONENTIAL 2026 Unusual Machines to stage live drone ecosystem demonstrations at XPONENTIAL 2026 in Detroit, Michigan, May 11-14, 2026. Demonstrations set for Booth 20013 fly cage, featuring deployment-ready defense and enterprise systems with par
05-08 20:30
The rapid proliferation of low-cost, highly capable airborne threats has created a growing challenge for defense organizations worldwide, driving demand for new approaches to aerial defense that can operate at speed and
05-01 20:38
Omnicell (NASDAQ:OMCL) released first-quarter financial results and hosted an e...
04-28 22:32
$1.67M Contract Expands XTEND's Footprint with Israeli Ministry of Defense, Reflecting Growing Demand for Deployable Autonomous Systems in Operational EnvironmentsTAMPA, Fla., April 21, 2026 (GLOBE NEWSWIRE) -- JFB
04-21 20:09
Phase 1 trial designed to assess the safety, pharmacokinetics and preliminary efficacy of VIR-5500 in both early and late-line metastatic castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive
04-13 20:07